Abstract
With the explosion of protein sequences generated in the postgenomic era, the gap between the number of attribute- known proteins and that of uncharacterized ones has become increasingly large. Knowing the key attributes of proteins is a shortcut for prioritizing drug targets and developing novel new drugs. Unfortunately, it is both time-consuming and costly to acquire these kinds of information by purely conducting biological experiments. Therefore, it is highly desired to develop various computational tools for fast and effectively classifying proteins according to their sequence information alone. The process of developing these high throughput tools is generally involved with the following procedures: (1) constructing benchmark datasets; (2) representing a protein sequence with a discrete numerical model; (3) developing or introducing a powerful algorithm or machine learning operator to conduct the prediction; (4) estimating the anticipated accuracy with a proper and objective test method; and (5) establishing a user-friendly web-server accessible to the public. This minireview is focused on the recent progresses in identifying the types of G-protein coupled receptors (GPCRs), subcellular localization of proteins, DNA-binding proteins and their binding sites. All these identification tools may provide very useful informations for in-depth study of drug metabolism.
Keywords: GPCR type, protein subcellular localization, DNA-binding protein, discrete model, PseAAC, protein attribute predictor, web-servers.
Current Topics in Medicinal Chemistry
Title:Recent Advances in Predicting Protein Classification and Their Applications to Drug Development
Volume: 13 Issue: 14
Author(s): Xuan Xiao, Wei-Zhong Lin and Kuo-Chen Chou
Affiliation:
Keywords: GPCR type, protein subcellular localization, DNA-binding protein, discrete model, PseAAC, protein attribute predictor, web-servers.
Abstract: With the explosion of protein sequences generated in the postgenomic era, the gap between the number of attribute- known proteins and that of uncharacterized ones has become increasingly large. Knowing the key attributes of proteins is a shortcut for prioritizing drug targets and developing novel new drugs. Unfortunately, it is both time-consuming and costly to acquire these kinds of information by purely conducting biological experiments. Therefore, it is highly desired to develop various computational tools for fast and effectively classifying proteins according to their sequence information alone. The process of developing these high throughput tools is generally involved with the following procedures: (1) constructing benchmark datasets; (2) representing a protein sequence with a discrete numerical model; (3) developing or introducing a powerful algorithm or machine learning operator to conduct the prediction; (4) estimating the anticipated accuracy with a proper and objective test method; and (5) establishing a user-friendly web-server accessible to the public. This minireview is focused on the recent progresses in identifying the types of G-protein coupled receptors (GPCRs), subcellular localization of proteins, DNA-binding proteins and their binding sites. All these identification tools may provide very useful informations for in-depth study of drug metabolism.
Export Options
About this article
Cite this article as:
Xiao Xuan, Lin Wei-Zhong and Chou Kuo-Chen, Recent Advances in Predicting Protein Classification and Their Applications to Drug Development, Current Topics in Medicinal Chemistry 2013; 13 (14) . https://dx.doi.org/10.2174/15680266113139990113
DOI https://dx.doi.org/10.2174/15680266113139990113 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Class II Phosphoinositide 3-Kinases as Potential Novel Drug Targets
Current Signal Transduction Therapy Determining Serum Levels of IL-10 and IL-17 in Patients with Low Back Pain Caused by Lumbar Disc Degeneration
Infectious Disorders - Drug Targets A Five-gene Signature for Predicting the Prognosis of Colorectal Cancer
Current Gene Therapy Assembly of Quinoline, Triazole and Oxime Ether in a Single Molecular Entity: A Greener and One-pot Synthesis of Novel Oximes as Potential Cytotoxic Agents
Letters in Drug Design & Discovery Novel Lactulose and Melibiose Targeting Autophagy to Reduce PolyQ Aggregation in Cell Models of Spinocerebellar Ataxia 3
CNS & Neurological Disorders - Drug Targets Targeting Ras-RAF-ERK and its Interactive Pathways as a Novel Therapy for Malignant Gliomas
Current Cancer Drug Targets Markov-Randic Indices for QSPR Re-Evaluation of Metabolic, Parasite- Host, Fasciolosis Spreading, Brain Cortex and Legal-Social Complex Networks
Current Bioinformatics Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials
Current Cancer Drug Targets Mucosal Immune Regulation and Vaccines for Helicobacter-associated Gastritis
Current Chemical Biology Complications of Anti-Vascular Endothelial Growth Factor Drugs
Current Drug Therapy Nanoparticles and Immune Cells
Current Pharmaceutical Design Applications of Micro/Nanotechnology in Ultrasound-based Drug Delivery and Therapy for Tumor
Current Medicinal Chemistry Targeting Different Signaling Pathways with Antisense Oligonucleotides Combination for Cancer Therapy
Current Pharmaceutical Design DNA Intercalators in Cancer Therapy: Organic and Inorganic Drugs and Their Spectroscopic Tools of Analysis
Mini-Reviews in Medicinal Chemistry Use of Insulin and Insulin Analogs and Risk of Cancer — Systematic Review and Meta-Analysis of Observational Studies
Current Drug Safety Membrane and Soluble Forms of Endoglin in Preeclampsia
Current Molecular Medicine Tissue Elasticity Bridges Cancer Stem Cells to the Tumor Microenvironment Through microRNAs: Implications for a “Watch-and-Wait” Approach to Cancer
Current Stem Cell Research & Therapy Advances of AKT Pathway in Human Oncogenesis and as a Target for Anti-Cancer Drug Discovery
Current Cancer Drug Targets Functional Nanoplatforms for Enhancement of Chemotherapeutic Index
Anti-Cancer Agents in Medicinal Chemistry Inhibiting Cyclin-Dependent Kinase / Cyclin Activity for the Treatment of Cancer and Cardiovascular Disease
Current Pharmaceutical Biotechnology